当前位置:首页 - 行情中心 - 赛诺医疗(688108) - 财务分析 - 现金流量表

赛诺医疗

(688108)

  

流通市值:119.66亿  总市值:119.66亿
流通股本:4.16亿   总股本:4.16亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金262,550,934.95110,597,804.2521,139,025.94358,433,488.89
  收到的税费返还37,31018,6681,035,502.98477,666.01
  收到其他与经营活动有关的现金9,741,243.534,714,508.6827,956,696.0720,874,109.64
  经营活动现金流入小计272,329,488.48115,330,980.88550,131,224.99379,785,264.54
  购买商品、接受劳务支付的现金31,001,029.9613,851,832.7575,983,363.2464,842,374.05
  支付给职工以及为职工支付的现金108,390,178.8163,385,203.35196,524,811.81153,028,280.97
  支付的各项税费27,272,871.8414,428,464.6330,714,086.4323,200,400.81
  支付其他与经营活动有关的现金53,214,988.5926,600,785.8115,668,927.3788,993,721.43
  经营活动现金流出小计219,879,069.2118,266,286.53418,891,188.85330,064,777.26
  经营活动产生的现金流量净额52,450,419.28-2,935,305.65131,240,036.1449,720,487.28
二、投资活动产生的现金流量:
  收回投资收到的现金--17,000,00017,000,000
  取得投资收益收到的现金--72,692.4672,692.46
  处置固定资产、无形资产和其他长期资产收回的现金净额34,393.29-832,732.84-
  收到的其他与投资活动有关的现金---2,025,522.94
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计34,393.29-17,905,425.319,098,215.4
  购建固定资产、无形资产和其他长期资产支付的现金24,385,010.9714,210,860.7870,016,585.7251,720,973.85
  投资支付的现金--17,000,00017,000,000
  取得子公司及其他营业单位支付的现金--20,352,687.1222,378,210.06
  投资活动现金流出小计24,385,010.9714,210,860.78107,369,272.8491,099,183.91
  投资活动产生的现金流量净额-24,350,617.68-14,210,860.78-89,463,847.54-72,000,968.51
三、筹资活动产生的现金流量:
  吸收投资收到的现金11,534,400-17,884,648.1217,152,937.94
  其中:子公司吸收少数股东投资收到的现金--2,505,448.121,773,737.94
  取得借款收到的现金47,900,00038,400,00081,000,00042,500,000
  收到其他与筹资活动有关的现金--60,480,00062,253,750
  筹资活动现金流入小计59,434,40038,400,000159,364,648.12121,906,687.94
  偿还债务支付的现金16,750,0007,250,00073,200,00039,200,000
  分配股利、利润或偿付利息支付的现金2,086,888.47968,655.74,109,806.053,048,443.94
  支付其他与筹资活动有关的现金21,286,740.1519,330,836.4320,587,054.4220,235,668.99
  筹资活动现金流出小计40,123,628.6227,549,492.1397,896,860.4762,484,112.93
  筹资活动产生的现金流量净额19,310,771.3810,850,507.8761,467,787.6559,422,575.01
四、汇率变动对现金及现金等价物的影响-610,758.41-306,567.22-209,328.53-842,477.08
五、现金及现金等价物净增加额46,799,814.57-6,602,225.78103,034,647.7236,299,616.7
  加:期初现金及现金等价物余额291,674,692.94291,674,692.94188,640,045.22188,640,045.22
  期末现金及现金等价物余额338,474,507.51285,072,467.16291,674,692.94224,939,661.92
补充资料:
  净利润13,168,411.05--3,889,480.61-
  资产减值准备-3,358,349.76-18,054,165.47-
  固定资产和投资性房地产折旧12,729,736.73-27,489,387.91-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧12,729,736.73-27,489,387.91-
  无形资产摊销19,796,642.55-38,451,540.03-
  长期待摊费用摊销12,117,320.12-24,388,180.46-
  处置固定资产、无形资产和其他长期资产的损失-32,667.63--287,342.75-
  固定资产报废损失17,306.44-85,874.13-
  财务费用3,130,591.63-5,800,352.37-
  投资损失---11,194,579.02-
  递延所得税4,277,505.32--12,076,798.84-
  其中:递延所得税资产减少12,183,022.54--6,555,285.98-
    递延所得税负债增加-7,905,517.22--5,521,512.86-
  存货的减少4,363,509.22-18,697,919.08-
  经营性应收项目的减少-7,503,510.18-10,313,976.64-
  经营性应付项目的增加-12,548,181.33-342,875.29-
  其他986,660-3,268,100-
  现金的期末余额338,474,507.51-291,674,692.94-
  减:现金的期初余额291,674,692.94-188,640,045.22-
  现金及现金等价物的净增加额46,799,814.57-103,034,647.72-
公告日期2025-08-222025-04-262025-04-262024-10-30
审计意见(境内)标准无保留意见
TOP↑